Thomas Herrin

531 total citations
16 papers, 376 citations indexed

About

Thomas Herrin is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Thomas Herrin has authored 16 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Organic Chemistry and 8 papers in Molecular Biology. Recurrent topics in Thomas Herrin's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (5 papers) and Biochemical and Molecular Research (4 papers). Thomas Herrin is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (5 papers) and Biochemical and Molecular Research (4 papers). Thomas Herrin collaborates with scholars based in United States and United Kingdom. Thomas Herrin's co-authors include Hing L. Sham, Daniel W. Norbeck, William Rosenbrook, Earl R. Kern, Jacob J. Clement, Ving J. Lee, Alan R. Branfman, Jacob J. Plattner, John E. Erickson and Seiji Hayashi and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Thomas Herrin

16 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Herrin United States 11 214 149 130 56 53 16 376
Harvey I. Skulnick United States 10 284 1.3× 169 1.1× 177 1.4× 120 2.1× 42 0.8× 14 522
Tien T. Duong United States 10 233 1.1× 232 1.6× 156 1.2× 90 1.6× 30 0.6× 15 438
John A. Bender United States 12 286 1.3× 97 0.7× 118 0.9× 59 1.1× 55 1.0× 18 459
Woo‐Baeg Choi United States 12 288 1.3× 247 1.7× 208 1.6× 101 1.8× 77 1.5× 20 564
David C. Humber United Kingdom 10 202 0.9× 173 1.2× 113 0.9× 47 0.8× 51 1.0× 30 334
Bounkham Thavonekham Canada 13 207 1.0× 131 0.9× 96 0.7× 51 0.9× 53 1.0× 20 388
M. G. YOUNG Malaysia 10 185 0.9× 208 1.4× 113 0.9× 30 0.5× 105 2.0× 12 419
Georges Maury France 14 269 1.3× 328 2.2× 211 1.6× 87 1.6× 73 1.4× 67 618
Janet C. Lynn United States 7 264 1.2× 110 0.7× 163 1.3× 121 2.2× 31 0.6× 10 465
William Rosenbrook United Kingdom 11 157 0.7× 173 1.2× 85 0.7× 26 0.5× 44 0.8× 22 346

Countries citing papers authored by Thomas Herrin

Since Specialization
Citations

This map shows the geographic impact of Thomas Herrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Herrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Herrin more than expected).

Fields of papers citing papers by Thomas Herrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Herrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Herrin. The network helps show where Thomas Herrin may publish in the future.

Co-authorship network of co-authors of Thomas Herrin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Herrin. A scholar is included among the top collaborators of Thomas Herrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Herrin. Thomas Herrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sham, Hing L., David A. Betebenner, William Rosenbrook, et al.. (2004). Novel lopinavir analogues incorporating heterocyclic replacements of six-member cyclic urea––synthesis and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 14(10). 2643–2645. 15 indexed citations
2.
Sham, Hing L., David A. Betebenner, Thomas Herrin, et al.. (2001). Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir). Bioorganic & Medicinal Chemistry Letters. 11(11). 1351–1353. 15 indexed citations
3.
Zhao, Chen, Clarence J. Maring, Kent D. Stewart, et al.. (2000). 58 Design, synthesis and activity of substituted pyrrolidine influenza neuraminidase inhibitors. Antiviral Research. 46(1). A53–A53. 3 indexed citations
4.
Sham, Hing L., Chen Zhao, Kennan C. Marsh, et al.. (1996). Novel Azacyclic Ureas That Are Potent Inhibitors of HIV-1 Protease. Biochemical and Biophysical Research Communications. 225(2). 436–440. 6 indexed citations
5.
Kempf, Dale J., Kennan C. Marsh, Hing L. Sham, et al.. (1994). Design of orally bioavailable, symmetry-based inhibitors of HIV protease. Bioorganic & Medicinal Chemistry. 2(9). 847–858. 40 indexed citations
6.
Norbeck, Daniel W., Hing L. Sham, William Rosenbrook, Thomas Herrin, & Jacob J. Plattner. (1992). Synthesis and Activities of the Phosphonate Isostere of the Monophosphate of (±)Cyclobut-G. Nucleosides and Nucleotides. 11(7). 1383–1391. 4 indexed citations
7.
Norbeck, Daniel W., Hing L. Sham, Thomas Herrin, William Rosenbrook, & Jacob J. Plattner. (1992). Synthesis of (±)-cycloprop-G, the cyclopropyl analogue of the broad spectrum antiviral agent cyclobut-G. Journal of the Chemical Society Chemical Communications. 0(2). 128–129. 11 indexed citations
8.
Norbeck, Daniel W., Earl R. Kern, Seiji Hayashi, et al.. (1990). Cyclobut-A and cyclobut-G: broad-spectrum antiviral agents with potential utility for the therapy of AIDS. Journal of Medicinal Chemistry. 33(5). 1281–1285. 105 indexed citations
9.
Herrin, Thomas, et al.. (1985). Preparation of biologically active ristocetin derivatives: replacements of the 1'-amino group. Journal of Medicinal Chemistry. 28(9). 1371–1375. 21 indexed citations
10.
Mao, Jialin, et al.. (1985). Structure-activity studies on phosphonoacetate. Antimicrobial Agents and Chemotherapy. 27(2). 197–202. 25 indexed citations
11.
Herrin, Thomas, et al.. (1980). THIOL ESTERS OF Nα-TOSYL-L-ARGININE. Organic Preparations and Procedures International. 12(3-4). 181–184. 1 indexed citations
12.
Lee, Ving J., Alan R. Branfman, Thomas Herrin, & Kenneth L. Rinehart. (1978). Acyl tetramic acids. 6. Synthesis of 3-dienoyl tetramic acids related to streptolydigin and tirandamycin. Journal of the American Chemical Society. 100(13). 4225–4236. 46 indexed citations
13.
Herrin, Thomas, et al.. (1977). ChemInform Abstract: SYNTHESIS AND ANTI‐HERPES SIMPLEX ACTIVITY OF ANALOGS OF PHOSPHONOACETIC ACID. Chemischer Informationsdienst. 8(39). 5 indexed citations
14.
Herrin, Thomas, et al.. (1977). Synthesis and anti-herpes simplex activity of analogs of phosphonoacetic acid. Journal of Medicinal Chemistry. 20(5). 660–663. 29 indexed citations
15.
Herrin, Thomas, et al.. (1975). Antimalarials. Synthesis and antimalarial activity of 1-(4-methoxycinnamoyl)-4-(5-phenyl-4-oxo-2-oxazolin-2-yl)piperazine and derivatives. Journal of Medicinal Chemistry. 18(12). 1216–1223. 14 indexed citations
16.
Johnson, William S., Charles A. Harbert, William R. Bartlett, et al.. (1970). Developments in the nonenzymic biogenetic-like steroid synthesis. Journal of the American Chemical Society. 92(14). 4461–4463. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harvey I. Skulnick Breakdown of academic impact, for papers by Tien T. Duong Breakdown of academic impact, for papers by John A. Bender Breakdown of academic impact, for papers by Woo‐Baeg Choi Breakdown of academic impact, for papers by David C. Humber Breakdown of academic impact, for papers by Bounkham Thavonekham Breakdown of academic impact, for papers by M. G. YOUNG Breakdown of academic impact, for papers by Georges Maury Breakdown of academic impact, for papers by Janet C. Lynn Breakdown of academic impact, for papers by William Rosenbrook
Rankless by CCL
2026